Skip to Content

'
Edith M. Marom, M.D.

Present Title & Affiliation

Primary Appointment

Professor, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1992 Sackler School of Medicine, Tel Aviv, Israel, MD, Magna Cum Laude, Medicine

Postgraduate Training

1997-1998 Thoracic Imaging Fellowship, Duke University Medical Center, Durham, NC
1995-1997 Post Graduate Studies in Radiology, Sackler School of Medicine, Tel Aviv, Israel
1995-1996 Radiology Residency Program, Rabin Medical Center, Petach Tikva, Israel
1993-1994 Radiology Residency Program, Auckland Hospital, Auckland, New Zealand
1992-1993 Post Graduate Studies in Radiology, Tel Aviv University, Tel Aviv, Israel
1992-1993 Radiology Residency Program, Rabin Medical Center, Petach Tikva, Israel
1992 Internal Medicine Residency, Rabin Medical Center, Petach Tikva, Israel
1992 Post Graduate Studies in Internal Medicine, Tel Aviv University, Tel Aviv, Israel
1990-1991 Rotating Internship, Ha-Sharon Hospital, Petach Tikva, Israel

Board Certifications

2006 American Board of Radiology
1996 Board Specialty Diagnostic Radiology (Israel)

Experience/Service

Academic Appointments

Associate Professor, Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2002-8/2008
Assistant Professor, Radiology Department, Duke University Medical Center, Durham, NC, 1999-2002
Radiology Department, Rabin Medical Center, Petach Tikva, Israel, 1998-1999
Radiology Department, Rabin Medical Center, Petach Tikva, Israel, 1996-1997

Other Appointments/Responsibilities

Item Writer for the American Board of Radiology: Diagnostic Radiology Initial Qualification Examination for the Pulmonary Category, American Board of Radiology, Scottsdale, AZ, 2008-present

Military or Other Governmental Service

Honorary Distinction: Lieutenant, The Israeli Defense Force, Completed Officer's Course with Honorary Distinction, 1983
Member, The Israeli Defense Force, Obligatory Two-year Military Service, 1982-1984

Institutional Committee Activities

Panelist, Developing a Career Plan in the Junior Faculty Retreat, 9/2011
Panelist, The Successful Academic Career in the Junior Faculty Development Program Retreat, 9/2010
Panelist, NTCA: Advice for Career Success at M. D. Anderson Panel Session, 2/2010
DI Departmental Liaison, Women Faculty Programs, 2010-present
Member, Diagnostic Radiology Research Committee, 2010-present
Member, Clinical Faculty Review Committee, 2008-present
Member, Education Committee, 2006-present
Member, Council of Goverence Committee, 2006-2009
Member, Faculty Senate Committee, 2006-2009
Member, Diversity Council Committee, 2006-2009
Member, Quality Assurance PET-CT Section, 2005-present
Member, Quality Assurance Chest Section, 2004-present

Honors and Awards

2012 Barbara Neibauer, A Celebration of Life Award, The Foundation for Thymic Cancer Research
2012 Certificate of Merit- Complications and Imaging Interpretation Pitfalls Following Chest Radiation Therapy, Radiological Society of North America
2012 Magna Cum Laude- Multidetector CT Evaluation of Airway Stents: What Radiologists Should Know, Society of Thoracic Radiology
2011 Certificate of Merit- Complications and Imaging Interpretation Pitfalls Following Chest Radiation Therapy, Radiological Society of North America
2011 Certificate of Merit- Multimodality Imaging Evaluation of Esophageal Cancer: Staging, Therapy Assessment and Complications, American Roentgen Ray Society
2011 Journal of Thoracic Imaging Editors' Recognition Award, Journal of Thoracic Imaging
2010 Certificate of Merit- Imaging Staging Evaluation and Treatment Considerations for Malignant Pleural Mesothelioma, Radiological Society of North America
2010 Cum Laude- Imaging, Staging Evaluation and Treatment Considerations in Thymoma, Radiological Society of North America
2010 Top 10 Article Cited in JTI Over the Last Decade: "Preoperative Evaluation of Patients with Malignant Pleural Mesothelioma: Role of Integrated CT-PET Imaging"
2008 Top 10 Papers in Mycology, "Reversed Halo Sign in invasive Pulmonary Fungal Infections", International Conference on Antimicrobial Agents and Infectious Diseases (ICAAC)
2004 Certificate of Merit, American Roentgen Ray Society
1989 Dean's List for Outstanding Studies
1988 Dean's List for Outstanding Studies
1987 Dean's List for Outstanding Studies

Professional Memberships

American College of Radiology
CPI Operations Advisory Group, 2009-present
Chair, CPI: Panel of Chest Section, 2006-present
Member, National Patterns of Care Lung Committee, 2006-present
Member, Radiation Therapy Oncology Group (RTOG), 2006-present
Doctor Challenger, 2005-present
Member, CPI: Panel of Chest Section, 2004-present
American Roentgen Ray Society
Scientific Program Subcommittee - Pulmonary Section, 2012-2014
Reviewer, Scientific Abstract Award Committee, 2011-present
Reviewer, Thoracic Imaging Scientific Abstract, 2011-present
ARRS Chest Instructional Course, 2009-present
Member, 1997-present
Harris County Medical Society
Member, 2007-present
International Association for the Study of Lung Cancer
Staging Committee Member, 2011-present
Member, 2006-present
International Thymic Malignancy Interest Group
Research Committee, Member, 2011-present
Education and Communication Committee Member, 2010-present
Head of the Educational Imaging Workgroup, 2010-present
Head of the Standard Reporting Imaging Workgroup, 2010-present
Chair of the Standards and Quality Workgroup, 2008-present
Founding Member, 2008-present
Radiological Society of North America
"Daily Bulletin" Editorial Board Member, 2012-2015
Member, American Association for Women Radiologists, 2010-present
Member, Scientific Program Committee, 2008-present
Panel Member, RadioGraphics Chest Poster Review Committee, 2004-present
Member, 1997-present
Society of Thoracic Radiology
Member, Research Committee, 2011-present
Member, Publication Committee, 2010-present
Member, Standards Committee, 2004-2010
Member, 1997-present
Texas Medical Association
Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Godoy MC, Bruzzi JF, Viswanathan C, Truong MT, Guimarães MD, Hofstetter WL, Erasmus JJ, Marom EM. Multimodality imaging evaluation of esophageal cancer: Staging, therapy assessment and complications. Abdom Imaging 38(5):974-93, 10/2013. e-Pub 5/2013. PMID: 23677485.
2. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM. Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome. AJR Am J Roentgenol 201(1):57-63, 7/2013. PMCID: PMC3767141.
3. Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, Marom EM. FDG PET-CT Aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. J Thorac Oncol 8(4):502-10, 4/2013. e-Pub 2/2013. PMCID: PMC3878071.
4. Haygood TM, Ryan J, Brennan PC, Li S, Marom EM, McEntee MF, Itani M, Evanoff M, Chakraborty D. On the choice of acceptance radius in free-response observer performance studies. Br J Radiol 86(1021):42313554, 1/2013. e-Pub 5/2012. PMCID: PMC3615402.
5. Marchiori E, Marom EM, Zanetti G, Hochhegger B, Irion KL, Godoy MC. Reversed halo sign in invasive fungal infections: criteria for differentiation from organizing pneumonia. Chest 142(6):1469-73, 12/2012. e-Pub 4/2012. PMID: 22539645.
6. Chakraborty DP, Haygood TM, Ryan J, Marom EM, Evanoff M, McEntee MF, Brennan PC. Quantifying the clinical relevance of a laboratory observer performance paradigm. Br J Radiol 85(1017):1287-302, 9/2012. e-Pub 5/2012. PMCID: PMC3487061.
7. Godoy MC, Viswanathan C, Marchiori E, Truong MT, Benveniste MF, Rossi S, Marom EM. The reversed halo sign: update and differential diagnosis. Br J Radiol 85(1017):1226-35, 9/2012. e-Pub 5/2012. PMCID: PMC3487053.
8. Marchiori E, Zanetti G, Escuissato DL, Souza AS, Meirelles GS, Fagundes J, Souza CA, Hochhegger B, Marom EM, Godoy MC. Reversed halo sign: high-resolution CT scan findings in 79 patients. Chest 141(5):1260-6, 5/2012. e-Pub 10/2011. PMID: 22016487.
9. Harvin JA, Lahat G, Correa AM, Lee JJ, Maru D, Ajani JA, Marom EM, Welsh J, Walsh GL, Roth JA, Mehran RJ, Vaporciyan AA, Rice DC, Swisher SG, Hofstetter WL. Neoadjuvant chemoradiation followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. Journal of Thoracic and Cardiovascular Surgery 143(2):412-420, 2/2012.
10. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-420, 2/2012. e-Pub 12/2011. PMID: 22172216.
11. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg 93(1):207-213, 1/2012. e-Pub 10/2011. PMCID: PMC4041623.
12. Tsao AS, Liu S, Fujimoto J, Wistuba II, Lee JJ, Marom EM, Charnsangavej C, Fossella FV, Tran HT, Blumenschein GR, Papadimitrakopoulou V, Kies MS, Hong WK, Stewart DJ. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. J Thorac Oncol 6(12):2104-11, 12/2011. PMID: 21892101.
13. Benveniste MF, Rosado-de-Christenson ML, Sabloff BS, Moran CA, Swisher SG, Marom EM. Role of imaging in the diagnosis, staging and treatment of thymoma. Radiographics 31(7):1847-1861, Nov-Dec, 11/2011. PMID: 22084174.
14. Betancourt SL, Palacio D, Jimenez CA, Martinez S, Marom EM. Thoracic manifestations of inflammatory bowel disease. AJR Am J Roentgenol 197(3):W452-456, 9/2011. PMID: 21862772.
15. Marom EM, Kontoyiannis DP. Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients. Curr Opin Infect Dis 24(4):309-314, 8/2011. PMID: 21673574.
16. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD, Marom EM. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395-409, 8/2011. e-Pub 6/2011. NIHMSID: NIHMS320819.
17. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-1281, 7/2011. PMID: 21623235.
18. Marom EM, Rosado-de-Christenson ML, Bruzzi JF, Hara M, Sonett JR, Ketai L. Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma. J Thorac Oncol 6(7, Suppl 3):S1717-23, 7/2011. PMID: 21847053.
19. Georgiadou SP, Sipsas NV,Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 52(9):1144-1155, 5/2011. PMCID: PMC3106265.
20. Tsao AS, Garland L, Redman M, Kernstine K, Gandara D, Marom EM. A practical guide of the southwest oncology group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria. J Thorac Oncol 6(3):598-601, 3/2011. PMCID: PMC3643692.
21. Palacio D, Mehran RJ, Marom EM. Esophageal luminal clot mimicking intramural esophageal hematoma. Ann Thorac Surg 91(2):e29, 2/2011. PMID: 21256262.
22. National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 258(1):243-253, 1/2011.
23. Marom EM. Imaging thymoma. J Thorac Oncol 10(4):S296-303, 10/2010. PMID: 20859123.
24. Milito MA, Kontoyiannis DP, Lewis RE, Liu P, Mawlawi OR, Truong MT, Marom EM. Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. Med Mycol 48(6):817-823, 9/2010. PMID: 20109093.
25. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: An orphan status. Ann Thorac Surg 90(3):884-891, 9/2010. PMID: 20732513.
26. Kalhor N, Marom EM, Moran CA. Primary myxoma of the lung. Ann Diagn Pathol 14(3):178-181, 6/2010. e-Pub 12/2009. PMID: 20471563.
27. Costelloe CM, Raymond AK, Fitzgerald NE, Mawlawi OR, Nunez RF, Madewell JE, Harrell RK, Bassett RL, Marom EM. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol 39(2):131-40, 2/2010. e-Pub 9/2009. PMID: 19760279.
28. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-868, 9/2009. PMID: 19699913.
29. Choi J, Marom EM, O'Sullivan PJ. Silicone inflammatory pseudotumor of the breast. European Journal of Radiology 70(1):e11-e13, 4/2009.
30. Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, Raymond AK, Lewis VO, Anderson PM, Bassett RL, Harrell RK, Marom EM. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 50(3):340-347, 3/2009. PMID: 19258257.
31. Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol 190(6):1605-9, 6/2008. PMID: 18492913.
32. Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis 46(11):1733-7, 6/2008. PMID: 18419427.
33. Yi JG, Kim SJ, Marom EM, Park JH, Jung SI, Lee MW. Chest CT of incidental breast lesions. J Thorac Imaging 23(2):148-55, 5/2008. PMID: 18520577.
34. Marom EM, Martinez CH, Truong MT, Lei X, Sabloff BS, Munden RF, Gladish GW, Herbst RS, Morice RC, Stewart DJ, Jimenez CA, Blumenschein GR, Onn A. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol 3(4):351 - 357, 4/2008. PMID: 18379352.
35. Ketai L, Jordan K, Marom EM. Imaging infection. Clin Chest Med 29(1):77-105, vi, 3/2008. PMID: 18267185.
36. Truong MT, Marom EM. Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer? Clin Lung Cancer 9(1):8, 1/2008. PMID: 18282351.
37. Bruzzi JF, Munden RF, Truong MT, Marom EM, Sabloff BS, Gladish GW, Iyer RB, Pan TS, Macapinlac HA, Erasmus JJ. PET/CT of esophageal cancer: its role in clinical management. Radiographics 27(6):1635 - 1652, Nov-Dec, 11/2007. PMID: 18025508.
38. Gladish GW, Rice DC, Sabloff BS, Truong MT, Marom EM, Munden RF. Pedicle muscle flaps in intrathoracic cancer resection: imaging appearance and evolution. Radiographics 27(4)(4):975-87, Jul-Aug, 7/2007. PMID: 17620462.
39. Won KS, Marom EM, Tateishi U, Namwongprom S, Kim EE. Pulmonary arteriovenous fistula arising in a renal cell carcinoma lung metastasis. Clin Radiol 62(8):812-816, 2007. PMID: 17604774.
40. Bruzzi JF, Truong MT, Marom EM, Mawlawi O, Podoloff DA, Macapinlac HA, Munden RF. Incidental findings on integrated PET/CT that do not accumulate 18F-FDG. AJR Am J Roentgenol 187(4):1116-1123, 10/2006. PMID: 16985164.
41. Bruzzi JF, Macapinlac H, Tsimberidou AM, Truong MT, Keating MJ, Marom EM, Munden RF. Detection of richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 47(8):1267-1273, 8/2006. PMID: 16883004.
42. Marom EM, Munden RF, Truong MT, Gladish GW, Podoloff DA, Mawlawi O, Broemeling LD, Bruzzi JF, Macapinlac HA. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer. J Thorac Imaging 21(3):205-212, 8/2006. PMID: 16915065.
43. Gladish GW, Choe DH, Marom EM, Sabloff BS, Broemeling LD, Munden RF. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 240(1):246-255, 7/2006. e-Pub 5/2006. PMID: 16684921.
44. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-86, 6/2006. PMID: 17409902.
45. Marom EM, Bruzzi JF, Truong MT. Extrathoracic PET/CT findings in thoracic malignancies. J Thorac Imaging 21(2):154-166, 5/2006. PMID: 16770232.
46. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 21(2):146-153, 5/2006. PMID: 16770231.
47. Marom EM, Chasen MH. Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study. AJR 1978; 131:51-54. AJR Am J Roentgenol 186(2):289-90, 2/2006. PMID: 16423928.
48. Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology 237(1):342-7, 10/2005. PMID: 16183941.
49. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 236(1):271-5, 7/2005. PMID: 15987980.
50. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 41(1):60-6, 7/2005. e-Pub 5/2005. PMID: 15937764.
51. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129(6):1364-70, 6/2005. PMID: 15942579.
52. Kim YH, Marom EM, Herndon JE, McAdams HP. Pulmonary vein diameter, cross-sectional area, and shape: CT analysis. Radiology 235(1):43-49; discussion 49-50, 4/2005. e-Pub 2/2005. PMID: 15731371.
53. Truong MT, Erasmus JJ, Macapinlac HA, Marom EM, Mawlawi O, Gladish GW, Sabloff BS, Bruzzi JF, Munden RF. Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls. J Comput Assist Tomogr 29(2):205-209, Mar-Apr, 3/2005. PMID: 15772538.
54. Choe DH, Marom EM, Ahrar K, Truong MT, Madewell JE. Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol 183(4):1097-1102, 10/2004. PMID: 15385313.
55. Truong MT, Erasmus JJ, Marom EM, Munden RF. Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma. Semin Roentgenol 39(3):386-396, 7/2004. PMID: 15372752.
56. Truong MT, Erasmus JJ, Sabloff BS, Marom EM, Gladish GW, Chasen MH, Munden RF. Pericardial "sleeve" recess of right inferior pulmonary vein mimicking adenopathy: computed tomography findings. J Comput Assist Tomogr 28(3):361-365, May-Jun, 5/2004. PMID: 15100541.
57. Marom EM, Moran CA, Munden RF. Generalized lymphangiomatosis. AJR Am J Roentgenol 182(4):1068, 4/2004. PMID: 15039189.
58. Marom EM, McAdams HP, Butnor KJ, Coleman RE. Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. J Thorac Imaging 19(2):74-78, 4/2004. PMID: 15071322.
59. Marom EM, Herndon JE, Kim YH, McAdams HP. Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation. Radiology 230(3):824-829, 3/2004. e-Pub 1/2004. PMID: 14739316.
60. Truong MT, Erasmus JJ, Gladish GW, Sabloff BS, Marom EM, Madewell JE, Chasen MH, Munden RF. Anatomy of pericardial recesses on multidetector CT: implications for oncologic imaging. AJR Am J Roentgenol 181(4):1109-1113, 10/2003. PMID: 14500241.
61. Marom EM, Palmer SM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Pleural effusions in lung transplant recipients: image-guided small-bore catheter drainage. Radiology 228(1):241-245, 7/2003. PMID: 12832585.
62. Marom EM, Palmer SM, Erasmus JJ, Herndon JE II, Zhang C, McAdams HP. Image-guided small bore catheter drainage of pleural effusions in lung transplant recipients. Radiology 228:241-245, 2003.
63. Marom EM, Goodman PC. Double-ring esophageal sign: pathognomonic for esophageal lipomatosis. J Comput Assist Tomogr 26(4):584-586, Jul-Aug, 7/2002. PMID: 12218824.
64. Marom EM, Erasmus JJ, Herndon JE, Zhang C, McAdams HP. Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. AJR Am J Roentgenol 179(1):105-108, 7/2002. PMID: 12076914.
65. Marom EM, Sarvis S, Herndon JE, Patz EF. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 223(2):453-459, 5/2002. PMID: 11997552.
66. Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE, Harpole DH, Goodman PC, Patz EF. Correlation of FDG-PET imaging with glut-1 and glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 33(2-3):99-107, Aug-Sep, 2001. PMID: 11551404.
67. Marom EM, Goodman PC, McAdams HP. Diffuse abnormalities of the trachea and main bronchi. AJR Am J Roentgenol 176(3):713-717, 2001. PMID: 11222211.
68. Flynn MJ, Eyler WR, Couwenhoven M, Slone R, Samei E, Whiting BR, Marom EM, and Foss DH. Equalization processing for digital chest radiographs. Radiology 221:688, 2001.
69. Marom EM, Goodman PC, McAdams HP. Focal abnormalities of the trachea and main bronchi. AJR Am J Roentgenol 176(3):707-711, 2001. PMID: 11222209.
70. Marom EM, Choi YW, Palmer SM, DeLong DM, Stuart MD, McAdams HP. Reperfusion edema after lung transplantation: effect of daclizumab. Radiology 221(2):508-514, 2001. PMID: 11687697.
71. Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer 28(3):187-202, 2000. PMID: 10812188.
72. Marom EM, Noyman M, Fink G, Yarmolovsky A, Cohen M, Kramer MR. The diagnostic approach in patients with hemoptysis. Harefuah 138(10):849-852, 2000. PMID: 10883253.
73. Marom EM, McAdams HP, Palmer SM, Erasmus JJ, Sporn TA, Tapson VF, Davis RD, Goodman PC. Cystic fibrosis: usefulness of thoracic CT in the examination of patients before lung transplantation. Radiology 213(1):283-288, 1999. PMID: 10540673.
74. Marom EM, Helms CA. Fibrolipomatous hamartoma: pathognomonic on MR imaging. Skeletal Radiol 28(5):260-264, 1999. PMID: 10424331.
75. Dodd LG, Marom EM, Dash RC, Matthews MR, McLendon RE. Fine-needle aspiration cytology of "ancient" schwannoma. Diagn Cytopathol 20(5):307-311, 1999. PMID: 10319234.
76. Patz EF, Erasmus JJ, McAdams HP, Connolly JE, Marom EM, Goodman PC, Leder RA, Keogan MT, Herndon JE. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology 212(1):56-60, 1999. PMID: 10405720.
77. Marom EM, Patz EF, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 210(1):277-281, 1999. PMID: 9885620.
78. Marom EM, Patz EF, Swensen SJ. Radiologic findings of bronchogenic carcinoma with pulmonary metastases at presentation. Clin Radiol 54(10):665-668, 1999. PMID: 10541392.
79. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF. Staging non-small cell lung cancer with whole-body PET. Radiology 212(3):803-809, 1999. PMID: 10478250.
80. Marom EM, McAdams HP, Erasmus JJ, Goodman PC. The many faces of pulmonary aspiration. AJR Am J Roentgenol 172(1):121-128, 1999. PMID: 9888751.
81. Marom EM, McAdams HP, Sporn TA, Goodman PC. Lentil aspiration pneumonia: radiographic and CT findings. J Comput Assist Tomogr 22(4):598-600, Jul-Aug, 1998. PMID: 9676451.
82. Marom EM, Porter A, Gornish M, Cohen M, Russo I. Atypical skeletal tuberculosis. Skeletal Radiol 24(8):620-622, 1995. PMID: 8614865.
83. Arber N, Liberman E, Vered G, Fink G, Marom EM, Sinai Y, Shiber A, Pinkhas J, Aronson M, Berliner S. Cathecholainine-associated changes in the state of leukocyte adhesiveness/aggregation in the peripheral blood. Stress Medicine 9:75-82, 1993.
84. Arber N, Berliner E, Marom EM, Rotenberg J, Pinkhas J, Aronson M. Determination of the state of leukocyte adhesiveness/aggregation in the peripheral blood of patients with chest pain. Cardiovasc Rev Rep 6:48-50, 1991.

Invited Articles

1. Marom EM. Advances in thymoma imaging. J Thorac Imaging 28(2):69-83, 3/2013. PMID: 23422781.
2. Rosado-de-Christenson ML, Strollo DC, Marom EM. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin North Am 22(3):409-31, 6/2008. PMID: 18514124.
3. Marom EM. "CT of the solitary pulmonary nodule"--a commentary. AJR Am J Roentgenol 190(5):1154-5, 5/2008. PMID: 18430823.
4. Balachandran D, Adachi R, Marom EM. Can CT pulmonary angiography allow assessment of severity and prognosis in patients presenting with pulmonary embolism? What the radiologist needs to know. Radiographics 26:39-40, 2006.
5. Marom EM, Chasen MH. Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study. AJR Am J Roentgenol 186:289-290, 2006.
6. Marom EM, Erasmus JJ, Pass HI, Patz EF. The role of imaging in malignant pleural mesothelioma. Semin Oncol 29(1):26-35, 2/2002. PMID: 11836666.

Abstracts

1. Marom, Mawlawi O, Truong MT, Rohren E. PET/CT in the thorax: Interpretation pitfalls and future developments. Radiological Society of North America Annual Meeting, 11/2012.
2. Marom EM, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. 40th Congress of the International Society of Oncology and Biomarkers, Jerusalem Israel, 10/2012.
3. Marom EM, ElNayal E, Moran CA, Fox PS, Mawlawi O, Swisher SG. Primary salivary gland type lung cancer: imaging and clinical predictors of outcome. 40th Congress of the International Society of Oncology and Biomarkers, Jerusalem, Israel, 10/2012.
4. Marom EM, Mawlawi O, Truong M. PET-CT in the Thorax: Interpretation Predicaments. American Roentgen Ray Society Annual Meeting, Vancouver, Canada, 5/2012.
5. Marom EM. Imaging of anterior mediastinal masses: a paradigm shift. American Association of Thoracic Surgery Annual Meeting, San Francisco, CA, 4/2012.
6. Marom EM. Scanlon symposium: MRI and PET imaging of thymic malignancy. Society of Thoracic Radiology, Huntington Beach, California, 3/2012.
7. Benveniste AP, Yang W, Benveniste MF, Mawlawi O, Fox PS, Marom EM. Incidental primary breast cancer detected at FDG PET-CT Imaging for non-mammary malignancies incidental primary breast cancer detected at FDG PET-CT Imaging for non-mammary malignancies. Radiological Society of North America Annual Meeting, Chicago, Illinois, 2012.
8. Benveniste AP, Yang WT, Benveniste MK, Mawlawi O, Fox PS, Marom EM. PET-CT detection of nonmammary malignancy metastatic to breast: Correlation with mammogram, ultrasound and histopathology. Radiological Society of North America Annual Meeting, Chicago, Illinois, 2012.
9. Betancourt SL, Palacio D, Benveniste MF, Godoy MC, Gomez D, Marom EM. Complications and imaging interpretation pitfalls following chest radiation therapy. Radiological Society of North America Annual Meeting, 11/2011.
10. Viswanathan C, Truong MT, Godoy M, Munden R, Erasmus J, Marom EM. Complications of oncologic therapy in the chest. Radiological Society of North America Annual Meeting, 11/2011.
11. Rohren E, Truong MT, Marom EM. PET/CT in the thorax: Interpretation, pitfalls and future developments (How-to workshop). Radiological Society of North America Annual Meeting, 11/2011.
12. Godoy MC, Viswanathan C, Truong MT, Marchiori E, Benveniste MF, Marom EM, Rossi S. The reversed halo sign: Update and differential diagnosis. Radiological Society of North America Annual Meeting, 11/2011.
13. Haygood TM, Ryan J, Brennan PC, Li S, Marom EM, McEntee M, Evanoff MG, Chakraborty D. Effect of varying acceptance radius on FROC performance. The XIV Medical Image Perception Society Conference, MIPS 2011, Dublin, Ireland, 8/2011.
14. Chakraborty D, Haygood TM, Ryan J, Marom EM, Evanoff MG, McEntee M, Brennan PC. Quantifying the clinical relevance of a laboratory observer performance paradigm. The XIV Medical Image Perception Society Conference, MIPS 2011, 8/2011.
15. Marom EM. Thymoma: a new paradigm in imaging staging and management. Society of Thoracic Radiology Annual Meeting, Fort Lauderdale, FL, 3/2011.
16. Marom EM. Imaging of invasive fungal pneumonia in 2010. Infectious Disease Society of America 48th Annual Meeting, Vancouver, Canada, 10/2010.
17. Marom EM, Milito MA, Moran CA, Liu P, Kim ES, Swisher SG. CT findings predicting invasiveness of thymoma. International Thymic Malignancy Interest Group, New York, New York 5(10):S370, 5/2010.
18. Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Swisher SG. Pathologic T0N1 after neoadjuvant therapy and surgery for esophageal cancer: an orphan status. The Society of Thoracic Surgeons 46th Annual Meeting, Fort Lauderdale, FL, 1/2010.
19. Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Swissher SG, Ajani JA, Chang JY, Marom EM, Maru DM, Macapinlac HA, Lee JH. Enhancing the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research and advocacy. The Society of Thoracic Surgeons, 46th Annual Meeting, Fort Lauderdale, FL, 2010.
20. Marom EM. Imaging techniques. First International Conference on Thymic Malignancies, Bethesda, MD, 8/2009.
21. Marom EM, Milito MA, Lewis RE, Liu P, Kontoyiannis DP. Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. 2nd World Congress of Thoracic Imaging and Diagnosis in Chest Disease, 2009.
22. Marom EM, Mawlawi O, Truong M, Rohren E. Thoracic PET-CT: interpretations predicaments and future developments. American Roentgen Ray Society Annual Meeting, Boston, MA, 2009.
23. Marom EM, Swisher SG, Kim ES, Moran C. Thymoma size is not a predictor for extracapsular invasion. 2nd World Congress of Thoracic Imaging and Diagnosis in Chest Disease, Valencia, Spain, 2009.
24. Kelliher E, Alzahrani A, Ramadan T, NiMhuircheartaigh J, Marom EM, Bruzzi J. Tumors and masses of the pleura and chest wall: what the radiologist should know. The European Congress of Radiology, Vienna, Educational Exhibit C-280, 2008.
25. Marom EM. Cavitation and hemotysis in lung cancer patients receiving antivascular agents. Annual Meeting of the Radiological Society of North America, Chicago, Illinois, 11/2007.
26. Marom EM. Current status of lung cancer screening. 5th Annual Current Trends in Cardiothoracic Surgery, Houston, Texas, 2007.
27. Marom EM. Esophageal cancer. The University of Texax M. D. Anderson Oncologic Imaging for the Practicing Radiologist: PET & PET/CT, Charleston, SC, 2007.
28. Marom EM. Lung cancer: staging, restaging, and surveillance. The University of Texas M. D. Anderson Oncologic Imaging for the Practicing Radiologist: PET & PET/CT, Charleston, SC, 2007.
29. Marom EM. PET/CT: A thoracic radiologist's perspective. The University of Texas M. D. Anderson Oncologic Imaging for the Practicing Radiologist: PET & PET/CT, Charleston, South Carolina, 2007.
30. Marom EM. Pulmonary manifestations of novel cancer therapies. Society of Thoracic Radiology, Las Vegas, Nevada, 2007.
31. Martinez CH, Marom EM, Herbst RS, Morice RC, Stewart DJ, Jimenez CA, Riddle JR, Onn A. Characteristics of lung cancer patients who develop tumor cavitation following therapy with angiogenesis inhibitors. The 102nd Annual Conference of the American Thoracic Society, San Diego, CA:#A97 (#A97), 5/2006.
32. Marom EM, Munden RF, Truong MT, Podoloff DA, Mawlawi O, Macapinlac HA. Inter and intra-observer variability of standardized uptake value measurements on integrated PET-CT for non-small-cell lung cancer. Israel Radiological Association (ISRA) Annual Meeting, 2006.
33. Marom EM, Herbst RS, Martinez CH, Onn A. Lung cancer patients who develop cavitation during therapy with anti-angiogenic agents. Israel Radiological Association (ISRA) Annual Meeting, 2006.
34. Marom EM, Erasmus JJ, Munden RF, Truong MT, Swisher SG. The accuracy of PET-CT assessment of tumor response in patients with esophageal cancer following pre-operative chemoradiation. Israel Radiological Association (ISRA) Annual Meeting, 2006.
35. Marom EM, Yi JG, Munden RF, Truong MT, Macapinlac HA, Podoloff DA. The significance of focal thyroid FDG uptake in patients initially staged with PET-CT for newly diagnosed non-small cell lung cancer. Israel Radiological Association (ISRA) Annual Meeting, 2006.
36. Bruzzi JF, Truong MT, Erasmus JJ, Marom EM, Martin D, Munden RF. 18-FDG PET/CT in the evaluation of benign and malignant pleural effusions. Radiological Society of North America, Chicago, Illinois, 2005.
37. Truong MT, Mawlawi O, Bruzzi JF, Marom EM, Macapinlac H, Erasmus JJ. Artifacts from the use of CT for attenuation correction in integrated PET/CT in oncologic imaging. Radiological Society of North America, Chicago, Illinois, 2005.
38. Truong MT, Erasmus JJ, Swisher S, Marom EM, Bruzzi JF, Munden RF. Integrated CT-PET in restaging of patients with potentially resectable esophageal malignancy after induction chemoradiation. Radiological Society of North America, Chicago, Illinois, 2005.
39. Bruzzi JF, Truong MT, Gladish GW, Sabloff BS, Marom EM, Erasmus JJ. Unusual and uncommon presentations of esophageal cancer metastases on PET/CT imaging. Radiological Society of North America, Chicago, Illinois, 2005.
40. Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol. Royal HD. Editor, Yearbook of Nuclear Medicine, Mosby. St. Louis, Missouri 183(4):1127-1132, 10/2004.
41. Truong MT, Erasmus JJ, Gladish GW, Sabloff BS, Marom EM, Madewell JE, Chasen MH, Munden RF. Anatomy of the pericardial recesses: visualization on multidetector CT and implications for oncologic imaging. Annual Meeting of American Roentgen Ray Society, 2004.
42. Truong MT, Erasmus JJ, Munden RD, Marom EM, Podoloff DA Macapinlac HA. Integrated PET/CT in patient with non-small cell lung cancer: normal variants and pitfalls. Radiological Society of North America, Chicago, Illinois, 2004.
43. Marom EM, Munden RF, Truong MT, Podoloff DA, Mawlawi O, Macapinlac HA. Inter and intra-observer variability of standardized uptake value measurements on integrated PET-CT for non-small-cell lung cancer. Radiological Society of North America, Chicago, Illinois, 2004.
44. Gladish GW, Rice DC, Sabloff BS, Truong MD, Marom EM, Munden RF. Pedicled Muscle Flaps in Intrathoracic Resection: Imaging Appearance and Evolution. Radiological Society of North America, Chicago, Illinois, 2004.
45. Munden RF, Truong MT, Marom EM, Sabloff BS, Podoloff DA, Macapinlac HA. Should the CT from PET/CT Be Interpreted? CT Findings That Do NOT Have Correlative F-18 FDG Activity in Non-Small Cell Lung Cancer. Radiological Society of North America, Chicago, Illinois, 2004.
46. Marom EM, Yi JG, Munden RF, Truong MT, Macapinlac HA, Podoloff DA. The significance of focal thyroid FDG uptake in patients initially staged with PET-CT for newly diagnosed non-small-cell lung cancer. Radiological Society of North America, Chicago, Illinois, 2004.
47. Marom EM, Choe DH, Ahrar K, Madewell JE. Pulmonary embolism caused by acrylic cement during percutaneous vertebroplasty and kyphoplasty: frequency, radiographic findings, and clinical significance. Radiological Society of North America, Chicago, Illinois, 2003.
48. Marom EM, Sarvis S, Herndon JE II, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Yearbook of Diagnostic Radiology, St. Louis, Missouri 223:453-459, 2003.
49. Onn A, Marom EM, Isobe T, Choe DH, Correa AM, Putnam JB, Herbst RS. Tumor cavitation is associated with epidermal growth factor expression and is a predictor of poor outcome in patients with stage I non-small cell lung cancer. American College of Chest Physicians Annual Meeting, Orlando, Florida, 2003.
50. Onn A, Marom EM, Choe DH, Correa AM, Putnam JB, Herbst RS. Tumor cavitation is associated with epidermal growth factor expression and is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Radiological Society of North America, Chicago, Illinois, 2003.
51. Kim YH, Marom EM, and McAdams HP. Utility of positron emission tomography with fluoro-2-deoxy-d-glucose (FDG) for differentiating opportunistic infection from malignancy in lung transplant recipients. Society of Thoracic Imaging, Miami Beach, Florida, 2003.
52. Marom EM, Patz EF, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE II. Treatment of malignant pleural effusions with small-bore catheter thoracostomy and talc sclerotherapy. Society of Thoracic Radiology, San Juan Peurto Rico, 1998.

Book Chapters

1. de Groot PM, Marom EM. Diagnostic imaging of lung and pleural tumors. In: Pleuro-pulmonary neoplasia. Ed(s) Moran CA, Weissferdt A. Springer, New York, 2013.
2. Marom EM, Onn A, McAleer MF. Complications in the oncologic patient: Chest. In: Silverman P. Oncologic Imaging: A Multidisciplinary Approach. Saunders Elsevier: Philadelphia, 2010.
3. Bruzzi J, Marom EM, Hofstetter W, McAleer MF. Esophageal cancer. In: Silverman P. Oncologic Imaging: A Multidisciplinary Approach. Saunders Elsevier, 2010.
4. Marom EM. Imaging tumors of the lung and pleura. In: Tumors and Tumor-Like Conditions of the Lung and Pleura. Ed(s) Moran C and Suster S. Saunders Elsevier, 2010.
5. Haygood TM, Marom EM, Weber DM. Myeloma and leukemia: Chest. In: Silverman P. Oncologic Imaging: A Multidisciplinary Approach. Saunders Elsevier: Philadelphia, 2010.
6. Gutierrez CJ, Marom EM, Erasmus JJ, Patz Jr. EF. Radiologic imaging of thoracic abnormalities. In: Sebastian and Spencer Surgery of the Chest. 1, 8. Ed(s) Sellke FW, del Nido PJ, Swanson SJ. Saunders, Elsevier: Philadelphia, 25-37, 2009.
7. Marom EM, Erasmus JJ, Patz Jr EF. Radiology: Interventional. In: Textbook of Pleural Diseases 2nd Edition, 2. Ed(s) Light RW, Lee YCG. Hodder Arnold Publishers: London, 259-270, 2008.
8. Marom EM, Bruzzi JF. Artifacts and pitfalls in PET-CT. In: Drouillard J and Frija G. Formation Medicale Continue JFR High Tech Imaging. Societe Francaise de Radiologie: France, 2006.
9. Gutierrez J, Marom EM, Erasmus JJ, Patz EF Jr. Imaging the thorax. In: Sabiston and Spencer Surgery of the Chest, 7th. Elsevier Saunders: Philadelphia, 19-32, 2005.
10. Marom EM, Erasmus JJ, Patz EF Jr. Interventional radiology for pleural diseases. In: Textbook of Pleural Diseases, 1st. Arnold: London, 238-248, 2003.
11. Marom EM, Goodman PC. The ICU chest. In: Radiologic Diagnosis of Chest Disease, 2nd. Springer-Verlag: London, 562-582, 2000.

Letters to the Editor

1. Godoy MC, Marom EM. Reversed halo sign in pulmonary zygomycosis. Thorax 66(6):544, 6/2011. e-Pub 3/2011. PMID: 21386105.
2. Marom EM. Fluid removal limitations in thoracentesis. Response to letters to the editor. AJR Am J Roentgenol 180:541, 2003.
3. Marom E. The diaphanous diaphragm: previously described. AJR Am J Roentgenol 179(4):1074, 10/2002. PMID: 12239072.
4. Marom EM. Non-small cell lung cancer: staging at whole-body PET. Response to letters to the editor. Radiology 217:918-919, 2000.

Manuals, Teaching Aids, Other Teaching Publications

1. Marom EM. Chest Radiology Questions. In: American College of Radiology Continuous Professional Improvement, 2012.
2. Marom EM. Chest Radiology Questions. In: American College of Radiology Continuous Professional Improvement, 2010.
3. Marom EM. Chest Radiology Questions. In: American College of Radiology Continuous Professional Improvement. 2009.
4. Marom EM. Chest Radiology Questions. In: American college of radiology continuous professional improvement. 2008.
5. Marom EM. Chest Radiology Questions. In: American College of Radiology Continuous Professional Improvement. 2007.
6. Marom EM, Truong MT. PET/CT with intravenous contrast and artifacts. Proceedings of Southeastern Chapter of Society of Nuclear Medicine, 47th Annual Meeting, 9/2006.
7. Marom EM, Bruzzi JF. Artifacts and pitfalls in PET-CT (CD-Rom) EDS. Drouillard J and Frija G. Formation Medicale Continue JFR High Tech Imaging, 2006.
8. Marom EM. Chest Radiology Questions. In: American College of Radiology Continuous Professional Improvement. American College of Radiology Continuous Professional Improvement, Ed: Diane Strollo, 2006.
9. Marom EM. Chest Radiology Questions. American College of Radiology Continuous Professional Improvement, Ed: Diane Strollo, 2005.
10. Marom EM. Case of the day lentil aspiration pneumonia. Education Site of the Society of Thoracic Radiology, http://www.thoracicrad.org, 2003.
11. Marom EM. Case EI101 scleroderma: pulmonary fibrosis. 2001.
12. Marom EM. Case EI102 scleroderma: pulmonary fibrosis. 2001.
13. Marom EM. Case EI103 rheumatoid arthritis: pulmonary fibrosis and pulmonary nodules. 2001.
14. Marom EM. Case EI104 ankylosing spondylitis: pulmonary fibrosis. 2001.
15. Marom EM. Case EI105 polymyositis: pulmonary fibrosis. 2001.
16. Marom EM. Case EI106 sjorgen syndrome: pulmonary fibrosis. 2001.
17. Marom EM, Patz EF Jr. Case EI107: acute lupus pneumonitis with pulmonary hemorrhage. 2001.
18. Marom EM, Patz EF Jr. Case EJ100: nitrofurantoin induced pulmonary disease. 2001.
19. Marom EM. Case EJ101: cyclophosphamide pulmonary toxicity. 2001.
20. Marom EM. Case EJ102 bleomycin toxicity. 2001.
21. Marom EM. Case EJ103 bleomycin toxicity. The Chest ACR Learning File, Ed: Rosado de Christenson, 2001.
22. Marom EM. Case EJ104 carmustine (BCNU) pulmonary toxicity. 2001.
23. Marom EM. Case EJ105 amiodarone lung toxicity. 2001.

Grant & Contract Support

Title: Can MRI Replace CT in the Evaluation of Thymoma?
Funding Source: DICRC
Role: Principal Investigator
Duration: 2/22/2011 - present
 
Title: Open, randomized comparative trial of two different schedules of liposomal Amphotericin B versus Voriconazole for the prevention of invasive fungal infections.
Funding Source: Novartis
Role: Collaborator
Principal Investigator: Mattiuzzi, G
Duration: 2007 - 2010
 
Title: A phase I/II study of TARCEVA (erlotinib) in combination with chemoradiation in patients with stage IIIA/B non-small cell lung cancer.
Funding Source: Genentech Inc.
Role: Collaborator
Principal Investigator: Ritsuko Komaki
Duration: 11/20/2006 - 12/31/2013
 
Title: Reference Image Database to Evaluate Response (RIDER)
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Munden R, Mendelsohn J
Duration: 9/28/2006 - 6/30/2007
 
Title: Contemporary screening for the detection of lung cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Munden, Reginald
Duration: 1/1/2006 - 12/31/2011
 
Funding Source: Sanofi-Aventis
Role: Collaborator
Principal Investigator: Herbst, Roy
Duration: 2006 - 2010
 
Title: Treatment of malignant pleural effusion with ZD6474, a novel vascular endothelial growth factor receptor (VEGR) and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
Funding Source: MDACC /DOD/AstraZeneca
Role: Collaborator
Principal Investigator: Roy Herbst
Duration: 2/1/2005 - 2/28/2013
 
Title: Phase II study of imatinib mesylate and docetaxel in pretreated patients with metastatic non-small cell lung cancer
Funding Source: Novartis
Role: Collaborator
Principal Investigator: Tsao, Anne
Duration: 2005 - 2011
 
Title: Comparison of CT and MRI in the preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism
Funding Source: Mike Hogg Fund
Role: Collaborator
Principal Investigator: Truong, Mylene
Duration: 2004 - 2007
 
Title: The measurement of hypoxia in non-small cell lung cancer
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Michael Kelley
Duration: 2002 - 2004

Last updated: 7/30/2014